Kuros Biosciences Ltd (CSBTF)
23.11
-1.09
(-4.50%)
USD |
OTCM |
Sep 20, 16:00
Kuros Biosciences Price to Book Value: 12.74 for Sept. 20, 2024
Price to Book Value Chart
Historical Price to Book Value Data
| Date | Value |
|---|---|
| September 19, 2024 | 13.34 |
| September 18, 2024 | 11.78 |
| September 17, 2024 | 11.78 |
| September 16, 2024 | 11.78 |
| September 13, 2024 | 12.56 |
| September 12, 2024 | 12.68 |
| September 11, 2024 | 11.85 |
| September 10, 2024 | 11.85 |
| September 09, 2024 | 11.04 |
| September 06, 2024 | 10.71 |
| September 05, 2024 | 11.03 |
| September 04, 2024 | 11.03 |
| September 03, 2024 | 11.03 |
| August 30, 2024 | 9.642 |
| August 29, 2024 | 9.642 |
| August 28, 2024 | 9.642 |
| August 27, 2024 | 10.44 |
| August 26, 2024 | 9.786 |
| August 23, 2024 | 9.786 |
| August 22, 2024 | 9.786 |
| August 21, 2024 | 9.786 |
| August 20, 2024 | 10.36 |
| August 19, 2024 | 9.229 |
| August 16, 2024 | 8.821 |
| August 15, 2024 | 8.270 |
| Date | Value |
|---|---|
| August 14, 2024 | 6.946 |
| August 13, 2024 | 8.418 |
| August 12, 2024 | 8.418 |
| August 09, 2024 | 8.418 |
| August 08, 2024 | 8.418 |
| August 07, 2024 | 8.418 |
| August 06, 2024 | 8.418 |
| August 05, 2024 | 8.418 |
| August 02, 2024 | 8.319 |
| August 01, 2024 | 8.319 |
| July 31, 2024 | 8.319 |
| July 30, 2024 | 7.713 |
| July 29, 2024 | 7.713 |
| July 26, 2024 | 7.713 |
| July 25, 2024 | 7.713 |
| July 24, 2024 | 7.713 |
| July 23, 2024 | 7.713 |
| July 22, 2024 | 7.713 |
| July 19, 2024 | 8.165 |
| July 18, 2024 | 7.553 |
| July 17, 2024 | 7.553 |
| July 16, 2024 | 7.553 |
| July 15, 2024 | 7.718 |
| July 12, 2024 | 7.691 |
| July 11, 2024 | 7.691 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
0.1067
Minimum
Dec 31 2019
13.34
Maximum
Sep 19 2024
1.909
Average
0.9447
Median
Jan 03 2023
Price to Book Value Benchmarks
| AC Immune SA | 2.645 |
| CRISPR Therapeutics AG | 2.073 |
| Addex Therapeutics Ltd | -- |
| NLS Pharmaceutics Ltd | -- |
| Molecular Partners AG | 0.8628 |
Price to Book Value Related Metrics
| PS Ratio | 14.60 |
| Price | 23.11 |
| Earnings Yield | -1.22% |
| Market Cap | 852.87M |